3-[(5-fluoro-1-benzofuran-7-yl)oxy]-N-[4-(2-hydroxypropan-2-yl)cyclohexyl]cyclobutane-1-carboxamide
C22H28FNO4 — CID 139369121
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[(5-fluoro-1-benzofuran-7-yl)oxy]-N-[4-(2-hydroxypropan-2-yl)cyclohexyl]cyclobutane-1-carboxamide
3-[(5-fluoro-1-benzofuran-7-yl)oxy]-N-[4-(2-hydroxypropan-2-yl)cyclohexyl]cyclobutane-1-carboxamide (PubChem CID 139369121) has the molecular formula C22H28FNO4 and a molecular weight of 389.47 g/mol. Its IUPAC name is 3-[(5-fluoro-1-benzofuran-7-yl)oxy]-N-[4-(2-hydroxypropan-2-yl)cyclohexyl]cyclobutane-1-carboxamide.
Molecular Properties
| Compound Name | 3-[(5-fluoro-1-benzofuran-7-yl)oxy]-N-[4-(2-hydroxypropan-2-yl)cyclohexyl]cyclobutane-1-carboxamide |
|---|---|
| PubChem CID | 139369121 |
| Molecular Formula | C22H28FNO4 |
| Molecular Weight | 389.47 g/mol |
| Exact Mass | 389.20 |
| IUPAC Name | 3-[(5-fluoro-1-benzofuran-7-yl)oxy]-N-[4-(2-hydroxypropan-2-yl)cyclohexyl]cyclobutane-1-carboxamide |
| SMILES | CC(C)(O)C1CCC(NC(=O)C2CC(Oc3cc(F)cc4ccoc34)C2)CC1 |
| InChI | InChI=1S/C22H28FNO4/c1-22(2,26)15-3-5-17(6-4-15)24-21(25)14-10-18(11-14)28-19-12-16(23)9-13-7-8-27-20(13)19/h7-9,12,14-15,17-18,26H,3-6,10-11H2,1-2H3,(H,24,25) |
| InChIKey | MMPRFIXPJDQIAV-UHFFFAOYSA-N |
| XLogP | 4.18 |
| TPSA | 71.70 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 389.47 |
| LogP ≤ 5 | 4.18 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139369121 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.